PDO

United States
United States
SEARCH FILTERS
Time filter
Source Type

News Article | April 20, 2017
Site: www.prweb.com

For anyone interested in continuing medical training, there are many courses available through Empire Medical Training. From April 21-24, Empire Medical Training will be expanding to New York City in order to supply the growing demand for dermal filler trainings. As President and founder of Empire Medical Training, Dr. Stephen Cosentino, DO states, “Our seminars are ideal for anyone looking to improve their medical practice. We provide the latest in medical advances as well as technology for learning.” This training complements other training for aesthetic injectables like Botox and dermal fillers. The average cost per patient is $600–$1800. The Platelet Rich Plasma for Aesthetics course is the first course for the weekend. PRP therapies require the separation of a patient's blood to extract autologous platelets, which are then activated to release adhesive glycoproteins. When the therapy is complete, this PRP releases healing proteins that help boost healing in your body. The main advantage of this type of aesthetic injectable versus other types, such as Botox, is that it is an all-natural, non-synthetic treatment. The training course will review all the purposes of PRP treatments. The training includes hands-on training and live demonstrations. Through Thread Lift Training, a class offered on April 22, students be trained to use Nu-Mesh® PDO thread sutures to lift and tighten the face with a material similar to thread used for surgical stitches. This revolutionary technique has many benefits to patients including no incision or downtime, no scarring or bruising, and immediate improvement of facial wrinkles. The morning will cover technique, protocols, preventing side effects, and treating complications. The afternoon will include a lecture combined with hands-on training in small groups. April 23 is a training on Nu-Lift® PDO Barbed Surgical Thread Lift. Because of the depth of the material, this training will be kept to just 10 students. This technique can be used on other parts of the body such as the stomach, legs, and arms. It can be used in combination on the face with Nu-Mesh to create a greater overall effect. The benefits are similar to that of the Nu-Mesh sutures. The training for this class will be one-on-one with live patients. The last class for that week, on April 24, is on advanced techniques for Botox and dermal fillers. This level II course covers the latest and most advanced injection techniques for Botox, Xeomin, and Dysport. The class will cover communicating expected results, dosing schedules, injection patterns, off label applications of dermal fillers, and advanced off label injections for ear lobe correction and more. For more information on the courses offered with Empire Medical Training, please visit their website.


“Discover our fisheries, competitive and sustainable” will be the slogan of the MAPAMA pavilion, where 22 Spanish companies will participate 3 April 2017: The Ministry of Agriculture and Fisheries, Food and Environment, henceforth MAPAMA, will participate for the twenty first time at Seafood Expo Global, one of the most important exhibitions worldwide, held in Brussels from the 25th to the 27th of April, 2017. The MAPAMA pavilion, located in Hall 7, will have an area of 224 m2. Within the pavilion will be represented the following Spanish associations: the Canned Fish and Seafood Manufacturers (ANFACO-CECOPESCA), the Spanish Association of Wholesalers, Importers, Manufacturers and Exporters of Fish products and Aquaculture (CONXEMAR) and the Business Association of Aquaculture of Spain (APROMAR). These associations will be accompanied by several companies representing different subsectors from the commercialization of the fresh, frozen, canned, and marine and continental aquaculture fishery products. Likewise, in Hall 7, the following Spanish regions will take part in the exhibition: Andalusia, Canary Islands, Catalonia, Galicia, Basque Country and Principality of Asturias. Furthermore, inside the MAPAMA pavilion will be set an institutional area with different informative panels related both to Spanish fisheries and aquaculture, and to their internationalization, all under the slogan “DISCOVER OUR FISHERIES, COMPETITIVE AND SUSTAINABLE”. Some panels will display information concerning Spanish Products under European quality schemes under the following message: “Spanish products. Quality products”, such as the Protected Designation of Origin (PDO) “Mexillon de Galicia-Mejillón de Galicia” (Galician Mussel), the Protected Geographical Indication (PGI) of “Caballa y Melva de Andalucía” (Mackerel and Frigate mackerel from Andalusia) and the PGI’s of “Mojama de Barbate” (Barbate Yellowfin tuna) and “Mojama de Isla Cristina” (Cristina’s Island Yellowfin tuna). Another panels will disclose the standard of the Spanish Association for Standardisation (AENOR), elaborated by the Technical Committee AEN/CTN 173 – processes and products of aquaculture, about the “Guide of Best Practice for sacrifice”, which establishes good practices for the stunning and sacrifice of marine and continental aquaculture fish destined to human consumption and related operations. Likewise, there will be a panel related with the “Spanish Products. Quality products”, where the so-called “Product of Estero” will be shown. This brand distinguishes and identifies a unique product, one that guarantees an environmentally sustainable production system and that is located in Protected Areas with high environmental and ecological value. In these case, it refers to the major wetland marshes that define the large rivers deltas along the Andalusian Atlantic coast. The brand “Atún de Pesca Responsable” (Tuna of Responsible Fishing) will also be exposed at the pavilion. The Spanish tuna fleet, grouped in OPAGAC (Organisation of Producers of Frozen Tuna), has promoted the publication of the first AENOR standard for the creation of a Spanish standard of requirements. This standard must be accomplished by the ships wishing to distinguish their catches as “Atún de Pesca Responsable”. The brand “Crianza de Nuestros Mares” (Breeding Our Seas) will also be exposed. For the first time, thanks to it, consumers will be able to identify fresh fish raised in our seas, like breams, sea bass and meagre. These could be identified by a brand label set in their gills as well as a trace code for each of the specimens. During the exhibition, the MAPAMA will organize an agenda with several business meetings, available to all Spanish participating companies and tailored to their individual needs. It will consist of potential business partner’s listings, with a selection of contacts of interest: importers, agents, or distributors. In addition, it will include the organization of individualized interviews with importers from other countries, reports on the product or service in the target market and practical information about the country of origin. The agenda will also include institutional meetings with foreign delegations, in order to promote export expansion of Spanish fishery products. These meetings will be attended by the Secretary General of Fisheries, Alberto Lopez – Asenjo García, Director-General for Fisheries Resources and Aquaculture, José Miguel Corvinos Lafuente, and the Director-General of Fisheries Management, José Luis González Serrano. The presence of Spain in this exhibition is funded by the Ministry of Agriculture and Fisheries, Food and Environment (MAPAMA) and by the European Union, through the European Maritime and Fisheries Fund (EMFF). Seafood Expo Global and Seafood Processing Global exhibition is the largest trade event of fish and seafood in the world, which holds its twenty-fifth edition. More than 26,000 buyers, suppliers, media and other professionals of the sector from more than 140 countries will visit it. Attendees come to meet with operators in other countries and establish contacts with other professionals in the fishing industry. In the previous edition of the year 2016, 1.664 exhibitors participated from 80 countries, a total of 35.862 m2, with 22.160 visitors from 143 countries.


Dr. Robert Burke Announces UltraSlim Cold Light Body Contouring is Now Available at the Michigan Center for Cosmetic Surgery Ultra Slim cold light body contouring now available at the Michigan Center for Cosmetic Surgery in Ann Arbor. This is the only FDA approved system for immediate reduction of fat without prescription medication, diet, or exercise. In FDA preapproval trials all patients benefited. Ann Arbor, MI, April 24, 2017 --( He also states that, “Ultra Slim cold light body contouring upends the present model for the nonsurgical treatment of unwanted fat resistant to diet and exercise since patients are comfortable during and after treatment, can immediately resume normal activities, and can see measurable results. With other technologies they usually have a period of recovery and a delay of up to 12 weeks before they can see any result.” “The advantage of this includes customization for patients based on their needs as determined by which body areas need to be targeted for treatment.” The Michigan Center for Cosmetic Surgery, directed by Robert H. Burke, MD,FACS is committed to the expansion and success of this noninvasive and minimally invasive division, providing solutions for those seeking ambulatory cosmetic surgery options. Previous additions to this division have included Bellafill for the long term correction of acne scars and facial volume loss (v lift), the Silhouette instalift (nonsurgical alternative to the facelift), and threadlifting with Miracu and PDO threads. Dr. Burke, is a Clinical Professor of Plastic and Reconstructive Surgery and a Clinical Professor of Facial Plastic Surgery at Michigan State University and well as an Adjunct Clinical Professor of Maxillofacial Surgery at the University of Michigan. He is principal investigator in FDA breast implant studies for both Mentor and Allergan Corporations, and in laser research, including tattoo removal lasers with Astanza corporation. He is also on the clinical advisory board of Suneva corporation. www.RobertBurke.com info@robertburke.com www.annarborcosmeticsurgery.com 1-800-487-4840 1-734-971-0262 Ann Arbor, MI, April 24, 2017 --( PR.com )-- Dr. Robert Burke, director of the Michigan center for Cosmetic Surgery announces the addition of Ultra Slim cold light body contouring. Noting cosmetic medicine and surgery trends in which men and women seek ambulatory solutions to common cosmetic concerns, a decision was made to add this innovative solution to fat accumulation in unwanted body areas. This FDA approved cold light body contouring process is the only FDA approved system for immediate fat reduction without prescription medications, diet, or exercise. “This fits directly into the mission of our division of minimally invasive and noninvasive cosmetic surgery, the first such division created in the United States associated with an accredited surgical center,” says Dr. Burke.He also states that, “Ultra Slim cold light body contouring upends the present model for the nonsurgical treatment of unwanted fat resistant to diet and exercise since patients are comfortable during and after treatment, can immediately resume normal activities, and can see measurable results. With other technologies they usually have a period of recovery and a delay of up to 12 weeks before they can see any result.”“The advantage of this includes customization for patients based on their needs as determined by which body areas need to be targeted for treatment.”The Michigan Center for Cosmetic Surgery, directed by Robert H. Burke, MD,FACS is committed to the expansion and success of this noninvasive and minimally invasive division, providing solutions for those seeking ambulatory cosmetic surgery options. Previous additions to this division have included Bellafill for the long term correction of acne scars and facial volume loss (v lift), the Silhouette instalift (nonsurgical alternative to the facelift), and threadlifting with Miracu and PDO threads.Dr. Burke, is a Clinical Professor of Plastic and Reconstructive Surgery and a Clinical Professor of Facial Plastic Surgery at Michigan State University and well as an Adjunct Clinical Professor of Maxillofacial Surgery at the University of Michigan. He is principal investigator in FDA breast implant studies for both Mentor and Allergan Corporations, and in laser research, including tattoo removal lasers with Astanza corporation. He is also on the clinical advisory board of Suneva corporation.www.annarborcosmeticsurgery.com1-800-487-48401-734-971-0262


News Article | April 19, 2017
Site: www.realclimate.org

Following on from the ‘interesting’ House Science Committee hearing two weeks ago, there was an excellent rebuttal curated by ClimateFeedback of the unsupported and often-times misleading claims from the majority witnesses. In response, Judy Curry has (yet again) declared herself unconvinced by the evidence for a dominant role for human forcing of recent climate changes. And as before she fails to give any quantitative argument to support her contention that human drivers are not the dominant cause of recent trends. Her reasoning consists of a small number of plausible sounding, but ultimately unconvincing issues that are nonetheless worth diving into. She summarizes her claims in the following comment: … They use models that are tuned to the period of interest, which should disqualify them from be used in attribution study for the same period (circular reasoning, and all that). The attribution studies fail to account for the large multi-decadal (and longer) oscillations in the ocean, which have been estimated to account for 20% to 40% to 50% to 100% of the recent warming. The models fail to account for solar indirect effects that have been hypothesized to be important. And finally, the CMIP5 climate models used values of aerosol forcing that are now thought to be far too large. These claims are either wrong or simply don’t have the implications she claims. Let’s go through them one more time. 1) Models are NOT tuned [for the late 20th C/21st C warming] and using them for attribution is NOT circular reasoning. Curry’s claim is wrong on at least two levels. The “models used” (otherwise known as the CMIP5 ensemble) were *not* tuned for consistency for the period of interest (the 1950-2010 trend is what was highlighted in the IPCC reports, about 0.8ºC warming) and the evidence is obvious from the fact that the trends in the individual model simulations over this period go from 0.35 to 1.29ºC! (or 0.84±0.45ºC (95% envelope)). Second, this is not how the attribution is done in any case. What actually happens is that the fingerprint of different forcings are calculated independently of the historical runs (using subsets of the drivers) and then matched to the observations using scalings for the patterns generated. Scaling factors near 1 imply that the models’ expected fingerprints fit reasonably well to the observations. If the models are too sensitive or not enough, that will come out in the factors, since the patterns themselves are reasonably robust. So models that have half the observed trend, or twice as much, can still help determine the pattern of change associated with the drivers. The attribution to the driver is based on the best fits of that pattern and others, not on the mean or trend in the historical runs. Patterns of variability that don’t match the predicted fingerprints from the examined drivers (the ‘residuals’) can be large – especially on short-time scales, and look in most cases like the modes of internal variability that we’ve been used to; ENSO/PDO, the North Atlantic multidecadal oscillation etc. But the crucial thing is that these residuals have small trends compared to the trends from the external drivers. We can also put these modes directly into the analysis with little overall difference to the results. 3) No credible study has suggested that ocean oscillations can account for the long-term trends The key observation here is the increase in ocean heat content over the last half century (the figure below shows three estimates of the changes since 1955). This absolutely means that more energy has been coming into the system than leaving. Now this presents a real problem for claims that ocean variability is the main driver. To see why, note that ocean dynamics changes only move energy around – to warm somewhere, they have to cool somewhere else. So posit an initial dynamic change of ocean circulation that warms the surface (and cools below or in other regions). To bring more energy into the system, that surface warming would have to cause the top-of-the-atmosphere radiation balance to change positively, but that would add to warming, amplifying the initial perturbation and leading to a runaway instability. There are really good reasons to think this is unphysical. Remember too that ocean heat content increases were a predicted consequence of GHG-driven warming well before the ocean data was clear enough to demonstrate it. Solar activity impacts on climate are a fascinating topic, and encompass direct radiative processes, indirect effects via atmospheric chemistry and (potentially) aerosol formation effects. Much work is being done on improving the realism of such effects – particularly through ozone chemistry (which enhances the signal), and aerosol pathways (which don’t appear to have much of a global effect i.e. Dunne et al. (2016)). However, attribution of post 1950 warming to solar activity is tricky (i.e. impossible), because solar activity has declined (slightly) over that time: 5) Aerosol forcings are indeed uncertain, but this does not impact the attribution of recent trends very much. One of the trickier issues for fingerprint studies is distinguishing between the patterns from anthropogenic aerosols and greenhouse gases. While the hemispheric asymmetries are slightly larger for aerosols, the overall surface pattern is quite similar to that for greenhouse gases (albeit with a different sign). This is one of the reasons why the most confident statements in IPCC are made with respect to the “Anthropogenic” changes all together since that doesn’t require parsing out the (opposing) factors of GHGs and aerosols. Therefore in a fingerprint study that doesn’t distinguish between aerosols and GHGs, what the exact value of the aerosol forcing right is basically irrelevant. If any specific model is getting it badly wrong, that will simply manifest through a scaling factor very different from 1 without changing the total attribution. What would it actually take to make a real argument? As I’ve been asking for almost three years, it is way past time for Curry to shore up her claims in a quantitative way. I doubt that this is actually possible, but if one was to make the attempt these are the kind of things needed: Absent any evidence to support these statements, the claim that somehow, somewhere the straightforward and predictive mainstream conclusions are fundamentally wrong just isn’t credible.


Dublin, April 24, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Italian Hard Cheese 2017" report to their offering. This is a report on the Italian Hard Cheese markets in the West and East Europe, Middle East and North Africa, Africa, Asia, Central Asia and Caucasus, Latin and North American regions. The report includes Italian EU PDO types but also locally produced Italian cheese types that have adopted traditional PDO designations but are produced outside the EU, e.g. in Argentina, Canada, US or Australia to name several markets. The report does not include regional or local varieties that may be adopted for similar consumption pattern usages, e.g. kefalotiri or kashkaval in the Balkans or Rumi cheese in Egypt. The report includes: - Information on supply and usage in 130 markets across the regions - Consumption volume (tonnes) and total market value ($/ million), 2011-2016 - Manufacturer supply (2016 only) - Volume Channel distribution split into retail, food service and industrial applications 2016 only - Local production versus imports at country and regional level for 2016 only Italian Hard Cheese is segmented into five categories: - Parmesan - Gran Padano - Asiago - Pecorino (includes romano in USA/Canada or Sardo in Argentina) - Other Italian Hard cheese Product sectors include Italian Hard Cheese segmented into wheel, grated, portion and others. The year series is 2011-2016, with forecasts to 2022. For more information about this report visit http://www.researchandmarkets.com/research/qpr74j/global_italian


Dublin, April 24, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Italian Hard Cheese 2017" report to their offering. This is a report on the Italian Hard Cheese markets in the West and East Europe, Middle East and North Africa, Africa, Asia, Central Asia and Caucasus, Latin and North American regions. The report includes Italian EU PDO types but also locally produced Italian cheese types that have adopted traditional PDO designations but are produced outside the EU, e.g. in Argentina, Canada, US or Australia to name several markets. The report does not include regional or local varieties that may be adopted for similar consumption pattern usages, e.g. kefalotiri or kashkaval in the Balkans or Rumi cheese in Egypt. The report includes: - Information on supply and usage in 130 markets across the regions - Consumption volume (tonnes) and total market value ($/ million), 2011-2016 - Manufacturer supply (2016 only) - Volume Channel distribution split into retail, food service and industrial applications 2016 only - Local production versus imports at country and regional level for 2016 only Italian Hard Cheese is segmented into five categories: - Parmesan - Gran Padano - Asiago - Pecorino (includes romano in USA/Canada or Sardo in Argentina) - Other Italian Hard cheese Product sectors include Italian Hard Cheese segmented into wheel, grated, portion and others. The year series is 2011-2016, with forecasts to 2022. For more information about this report visit http://www.researchandmarkets.com/research/qpr74j/global_italian


News Article | April 17, 2017
Site: www.marketwired.com

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 12, 2017) - Worldwide Marijuana Inc. (CSE:WWM)(CSE:WWM.CN) the "Company" or "Worldwide") is pleased to announce the appointment of a new management team to spearhead the recapitalization and reorganization of the Company. Incoming directors and officer appointments effective April 10, 2017 are as follows: Mr. Robert Marsh, former President and CEO of the Company, has resigned his executive appointments but will remain as a director to provide guidance and continuity to the new management team. The directors of the Company are therefore Rob van Santen, Annie Storey, and Bob Marsh. The immediate objective is to bring the Company's required filings up to date under National Instrument 51-102 of the Canadian Securities Administrators, which includes the audited annual financial statements with accompanying MD&A and Officer Certificates as at and for the years ended October 31, 2015 and 2016. After completion of these filings, the Company will re-apply to meet all the initial listing requirements of the Canadian Securities Exchange by way of a new Listing Application as a Life Sciences Issuer. Mr. van Santen has over 30 years of investment industry and financing experience, providing financial and intellectual capital to both private business and the public markets. He began his career in 1986 as an Investment Advisor with Burns Fry (now BMO Nesbitt Burns), was recognized as "Broker of the Year" in 1994, and left the industry as a Senior VP to establish family-controlled venture capital, merchant, and investment banking operations. Mr. van Santen is currently Managing Director of Agilis Capital Corp., CIO at Westland Capital Advisors S.A., and Chairman and CEO of Valens GroWorks Corp., a publicly-traded cannabis-focused company integrating an end-to-end global "plants to premium products" bioscience platform. Rob holds a Bachelor of Commerce degree in organizational behavior from Concordia University, Chartered Accountant, Chartered Professional Accountant, and Chartered Market Technician's designations, as well as certifications that include the Canadian Securities Institute's CSC (Honours), CPC (Honours), PDO and the OLC. Ms. Storey brings over 25 years of diverse financial reporting and management experience, including seventeen years in public practice in the areas of audit, accounting, and quality control with national (MNP) and international (KPMG) financial consulting and advisory firms. As a public company audit partner, she navigated complex regulatory environments to meet cross-border reporting requirements. Ms. Storey holds Chartered Accountant and Chartered Professional Accountant designations, has held teaching positions with the BCIT and the CA School of Business, and CFO and director positions with several publicly traded companies. Ms. Storey earned a Bachelor of Business Administration degree from Simon Fraser University with majors in finance and international business, and is a member of the Institute of Chartered Accountants of B.C.'s Practice Review & Licensing Committee, the Canadian Institute of Chartered Accountants' Practitioners' Technical Advisory Committee, and regularly participates on boards of non-profit organizations. "I welcome this opportunity to join Bob and Annie on the Board, and to apply corporate reorganization experience and connections to assist in the resurrection of Worldwide Marijuana. The rapidly growing medical-marijuana industry offers considerable opportunities for consolidation, with specific knowhow and solid operational experience in short supply." said Rob van Santen, incoming CEO. "With the talent and operational experience available within my growing network, our objective is to bring together a team that can capitalize on the myriad of timely opportunities the end of prohibition offers." On behalf of the Board of Directors, This press release contains forward-looking information based on current expectations. Statements about the Company's expectations are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Worldwide Marijuana assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek safe harbor.


News Article | May 23, 2017
Site: www.prnewswire.com

LONDON, May 23, 2017 /PRNewswire/ -- Spending and Production Forecasts for Polymers, Surfactants, Biopolymers and ASP & Forecast by Region Plus Profiles of Top Companies Report Details This latest report by business intelligence provider visiongain assesses that Chemical EOR spending will reach $2.56bn in 2017. This report addresses the development of the global Chemical EOR market, analysing the prospects for 6 technologies, 15 regional & national markets and including forecasts for Spending and production from 2017-2027. It is therefore critical that you have your timescales correct and your forecasting plans ready. This report will ensure that you do. Visiongain's report will ensure that you keep informed and ahead of your competitors. Gain that competitive advantage. Download the full report: https://www.reportbuyer.com/product/4911757/ The Chemical EOR Market Forecast 2017-2027 responds to your need for definitive market data: Read on to discover how you can exploit the future business opportunities emerging in this sector. Visiongain's new study tells you and tells you NOW. In this brand new report, you find 207 in-depth tables, charts and graphs all unavailable elsewhere. The 254 page report provides clear detailed insight into the global Chemical EOR market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand new report today you stay better informed and ready to act. Report Scope The report delivers considerable added value by revealing: 207 tables, charts and graphs analysing and revealing the growth prospects and outlook for the Chemical EOR. Chemical EOR market forecasts and analysis from 2017-2027. Chemical EOR market provides spending and production from 2017-2027 for 6 Chemical EOR technologies: • ASP • Polymer • Surfactant • Biopolymer • ASP/Polymer • Polymer/Surfactant Regional Chemical EOR market forecasts from 2017-2027 with drivers and restraints for the regions including: • China • Canada • Russia • Oman • Rest of Middle East • Indonesia • Venezuela • Colombia • Rest of Latin America • United States • India • Mexico • North Sea • Malaysia • Rest of the World Company profiles for the leading 10 Chemical EOR companies • BlackPearl Resources • Cenovus Energy • PetroChina (CNPC) • China National Offshore Oil Corporation (CNOOC) • Canadian Natural Resources (CNRL) • Murphy Oil Corporation • Petroleum Development Oman (PDO) • Rex Energy • Sinopec Corp • Zargon Oil and Gas Conclusions and recommendations which will aid decision-making How will you benefit from this report? • Keep your knowledge base up to speed. Don't get left behind • Reinforce your strategic decision-making with definitive and reliable market data • Learn how to exploit new technological trends • Realise your company's full potential within the market • Understand the competitive landscape and identify potential new business opportunities & partnerships Who should read this report? • Anyone with involvement in the Chemicals and Oil company • Energy price reporting companies • Energy company managers • Energy consultants • Oil and gas company executives and analysts • Heads of strategic development • Business development managers • Marketing managers • Market analysts, • Technologists • Suppliers • Investors • Banks • Government agencies Visiongain's study is intended for anyone requiring commercial analyses for the Chemical EOR market and leading companies. You find data, trends and predictions. Buy our report today the Chemical Enhanced Oil Recovery (EOR) Market 2017-2027: Spending and Production Forecasts for Polymers, Surfactants, Biopolymers and ASP & Forecast by Region Plus Profiles of Top Companies. Avoid missing out by staying informed – get our report now. visiongain is a trading partner with the US Federal Government Download the full report: https://www.reportbuyer.com/product/4911757/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chemical-enhanced-oil-recovery-eor-market-2017-2027-300462657.html


LONDON, May 11, 2017 /PRNewswire/ -- Middle East and North Africa Medical Aesthetic Devices Market: Overview Medical aesthetic devices are used in body contouring, dermal resurfacing, dermal tightening, acne prevention, hair removal, reduction of age related dermal or vascular lesions and reduction of skin pigmentation and blemishes. A wide range of devices are available for addressing these conditions such as dermal lasers, microdermal abraders, intense pulsed light devices, light emitting diodes (LEDs), infrared devices, radio frequency-based devices, dermal fillers, and implants. Factors prompting the adoption of medical aesthetic devices include the aging of the large baby boomer population that continues to demand anti-aging medical techniques, increasing disposable income and developing health and wellness sector. Download the full report: https://www.reportbuyer.com/product/4895316/ This report on the Middle East and North Africa medical aesthetic devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as technological developments, product innovation, expansion of healthcare infrastructure facilities in Middle East and North African countries, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the Middle East and North Africa medical aesthetic devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market. Middle East and North Africa Medical Aesthetic Devices Market: Segmentation In terms of application, Middle East and North Africa medical aesthetic devices market is segmented into facial and body contouring, facial & skin rejuvenation, breast enhancement, scar treatment, congenital defect repair, reconstructive surgery, tattoo removal, hair removal and vaginal rejuvenation and tightening. In terms of products, Middle East and North Africa medical aesthetic devices market is segmented into aesthetic laser and energy devices, skin tightening and body contouring devices, aesthetic implants and facial aesthetic devices. The aesthetic laser and energy devices segment is further categorized into ablative skin resurfacing devices and non-ablative skin resurfacing devices. Skin tightening and body contouring devices are segmented into liposuction devices, skin tightening devices and cellulite reduction devices. Aesthetic implants are categorized into breast implants, soft tissue implants, aesthetic dental implants and others. Facial aesthetic devices segment is further divided into microdermabrasion devices, botulinum toxin, dermal fillers and threads. In terms of end users, the Middle East and North Africa medical aesthetic devices market is segmented into hospitals, dermatology clinics and cosmetic centers Geographically, the Middle East and North Africa medical aesthetic devices market has been segmented into two regions: Middle East and North Africa. The regions have been further segmented by major countries. An overview of Middle East and North Africa has been provided, and the Middle East and North Africa region has been analyzed in depth at country as well as application, product and end-user segment level. The countries in Middle East include Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain, Iraq, Lebanon, Syria, Jordan and Rest of Middle East. The countries in North Africa include Egypt, Algeria, Morocco, Tunisia and Rest of Africa. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the Middle East and North Africa medical aesthetic devices market. Companies Mentioned in the Report The report also profiles major players in the Middle East and North Africa medical aesthetic devices market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Allergan plc., Mentor Worldwide LLC, Merz, Inc., ZELTIQ Aesthetic, Inc., Fosun Pharmaceutical Co., Ltd (Alma Lasers), Aptos Medical Aesthetics, Inc., Cynosure, Inc., Galderma S.A. (Nestle), Lumenis Ltd., Promoitalia, Solta Medical, Inc., Syneron Candela, TEOXANE Laboratories and Viveve Medical, Inc. The Middle East and North Africa medical aesthetic device market is segmented into: By Product Aesthetic Laser and Energy Devices Ablative Skin Resurfacing Devices Non-Ablative Skin Resurfacing Devices Skin Tightening and Body Contouring Devices Liposuction Devices Skin Tightening Devices Cellulite Reduction devices Aesthetic Implants Breast Implants Soft Tissue Implants Aesthetic Dental Implants Others Facial Aesthetic Devices Microdermabrasion Devices Botulinum Toxin Dermal Fillers (e.g. Teoxane fillers, etc.) Threads (e.g. Normal, PDO, etc.) By Application Facial and Body Contouring Facial & Skin Rejuvenation Breast Enhancement Scar Treatment Congenital Defect Repair Reconstructive Surgery Tattoo Removal Hair Removal Vaginal Rejuvenation and Tightening By End User Hospitals Dermatology Clinics Cosmetic Centers By Geography Middle East Saudi Arabia United Arab Emirates (UAE) Qatar Oman Kuwait Bahrain Iraq Lebanon Syria Jordan Rest of Middle East North Africa Egypt Algeria Morocco Tunisia Download the full report: https://www.reportbuyer.com/product/4895316/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medical-aesthetic-devices-market---middle-east-and-north-africa-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300456302.html


News Article | May 8, 2017
Site: www.prnewswire.com

·         Increasing vehicle production is driving the antifreeze market for the automotive industry. ·         The antifreeze market for original equipment is projected to grow at a CAGR of 5.18% from 2016 to 2021, to reach a market size of USD 885.1 million by 2021. ·         The growth of the automotive engine coolant market is directly linked to the rising vehicle production. ·         Passenger cars are expected to witness the highest demand for antifreeze. ·         According to OICA, the production of passenger cars around the globe has grown from 68.6 million units in 2015 to 72.1 million units in 2016 at a rate of 5.1%. ·         According to Trading Economics statistics, the U.S. GDP per capita increased from USD 50,727.8 in 2014 to USD 51,638.1 in 2015, which led to increased purchasing capabilities of consumers. ·         Glycerine is expected to be the fastest growing base product market for antifreeze in the automotive industry. ·         North America: Largest and fastest growing antifreeze market for the automotive industry in Original Equipment (OE) segment. "Increasing vehicle production is driving the antifreeze market for the automotive industry" The antifreeze market for original equipment is projected to grow at a CAGR of 5.18% from 2016 to 2021, to reach a market size of USD 885.1 million by 2021. According to the Organisation Internationale des Constructeurs d'Automobiles (OICA), the global vehicle production in 2015 was ~92 million units and is projected to grow to ~125 million units by 2021, at a CAGR of 5.40% from 2016 to 2021. This growth in vehicle production can be attributed to rising per capita income, increased preference for personal transport, and improved infrastructure. The growth of the automotive engine coolant market is directly linked to the rising vehicle production. Thus, rising vehicle production is one of the key drivers for the increase in demand for engine coolant in the original equipment market. Growing demand for battery operated vehicles is acting as a key restraint for the antifreeze market, especially in countries such as Norway, the Netherlands, and China, where the government has implemented stringent emission regulations. However, the impact of this growth is expected to be low for the next five years. "Passenger cars are expected to witness the highest demand for antifreeze" According to OICA, the production of passenger cars around the globe has grown from 68.6 million units in 2015 to 72.1 million units in 2016 at a rate of 5.1%. The increased sales of passenger cars is due to the improved standard of living and rise in per capita income in various countries. According to Trading Economics statistics, the U.S. GDP per capita increased from USD 50,727.8 in 2014 to USD 51,638.1 in 2015, which led to increased purchasing capabilities of consumers. Thus, the sales and production of passenger cars are increasing and leading to increased demand for engine coolant and antifreeze. "Glycerine is expected to be the fastest growing base product market for antifreeze in the automotive industry" Antifreeze base fluids are toxic in nature. This has compelled manufacturers to switch to less toxic alternatives. Also, glycols used for antifreeze are manufactured from crude oil filtration, which may lead to a higher demand for fossil fuels such as crude oil and can have a negative impact on the environment. Hence, bio-based options such as glycerin are getting recognized in the market for their environment-friendly nature. These bio-based antifreeze are manufactured from materials such as corn, stover, and other oil bearing resources. Manufacturers are venturing into this market with products such as the Susterra brand of DuPont Tate & Lyle Bio Products (U.S.), which is produced using a bio-based glycol named 1, 3-Propanediol (PDO). This glycol is completely manufactured using renewable and bio-based materials and is suitable for passenger cars and other light and heavy duty vehicles. "North America: Largest and fastest growing antifreeze market for the automotive industry in Original Equipment (OE) segment" The North American region leads the antifreeze market for the automotive industry, owing to the higher production and demand for large engine capacity vehicles in this region such as extended cabs. The automotive market in this region is inclined towards SUVs and light trucks, owing to their off-road capabilities and better traction in changing weather conditions. According to OICA, the light commercial vehicle production in North America increased from 10.4 million units in 2015 to 11.0 million units by 2016 at a rate of 5.7%, which is above the global growth rate of 2.7%. Also, LCVs in North America have a higher antifreeze requirement, as compared to other regions. These factors have contributed to the higher market size of automotive antifreeze in this region. Additionally, the automotive industry of North America is one of the most advanced across the globe with substantial investments in R&D activities, infrastructure, and new production facilities driving the overall automotive antifreeze market. BREAKDOWN OF PRIMARIES The study contains insights provided by various industry experts, ranging from antifreeze raw material suppliers to antifreeze/coolant manufacturers. The break-up of the primaries is as follows: - By Company Type: Tier-1—16%, Tier-2—67%, and OEMs—17% - By Designation: D level—16%, C-level—67%, and Other (includes R&D heads and experts from the chemical industry)—17% - By Region: North America—50%, Asia-Pacific—33%, Europe—17% The report provides detailed profiles of the following companies: - B.P. PLC. (U.K.) - Royal Dutch Shell PLC (Netherlands) - Total (France) - Chevron Corporation (U.S.) - Exxon Mobil Corporation (U.S.) - China Petrochemical Corporation (China) - BASF SE (Germany) - Cummins, Inc. (U.S.) - Motul (France) - Prestone Products Corporation (U.S.) Research Coverage: The report provides a picture of the antifreeze market across different verticals and regions for the automotive and off-highway industry. It aims at estimating the market size and future growth potential of the antifreeze OE by vehicle type, product, additive technology, construction equipment engine coolant OE market by application, and engine coolant aftermarket by additive technology and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, SWOT analysis, recent developments, and key market strategies. Reasons to Buy the Report: The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the antifreeze market in the automotive industry and the subsegments as well as for construction equipment. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities. Read the full report: http://www.reportlinker.com/p04883663/Antifreeze-Market-by-Vehicle-Type-Product-Engine-Coolant-Additive-Technology-OE-Aftermarket-Region-and-Construction-Equipment-Engine-Coolant-Market-by-Application-Forecast-to.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/antifreeze-market-to-reach-the-value-of-usd-8851-million-by-2021-300453649.html

Loading PDO collaborators
Loading PDO collaborators